FMP

FMP

Enter

CLSN - Imunon, Inc.

Profile of Imunon, Inc.(CLSN), Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commerci

About

ceo

Michael Tardugno

sector

Healthcare

industry

Biotechnology

website

https://celsion.com

exchange

NASDAQ

Description

Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.

CIK

0000749647

ISIN

US15117N6022

CUSIP

15117N602

Address

997 Lenox Dr Ste 100

Phone

16098969100

Country

US

Employee

29

IPO Date

Oct 27, 1993

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep